The slip
PARKINSON RECEIPTno. 8973
24 Oct 2026, 20:02 UTCdopamine neurons, braak
predictionDPM3 in dopamine neurons tracks Braak Lewy-body stage
registered06e66d9f40c4f84b
discovery-0.23 p=0.549 n=9
replication-0.16 p=0.689 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.23, p 0.549)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT49cd4485ada7af82548960c1…
follows 1452ef0a4ba3…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8973: DPM3 in dopamine neurons, braak
- power
- full sample -0.21 (p 0.408, n 18), 95% CI -0.61 to +0.29. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.19 (p 0.444, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.16 (p 0.538, n 18). could be the mix.
- skeptic
- leave-one-out range -0.33 to -0.10, sign flips 0; without severely affected donors -0.21 (p 0.408, n 18). fragile.
- cell type
- strongest in OPCs: +0.65 (p 0.0033, n 18) vs -0.21 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DPM3 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up DPM3 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.13 p 0.657 (needs p < 2.4e-4)